635 related articles for article (PubMed ID: 15477876)
21. Intermediate biomarkers for chemoprevention of prostate cancer.
van der Kwast TH
IARC Sci Publ; 2001; 154():199-205. PubMed ID: 11220659
[TBL] [Abstract][Full Text] [Related]
22. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
Epstein JI; Herawi M
J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
[TBL] [Abstract][Full Text] [Related]
23. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia.
Clouston D; Bolton D
BJU Int; 2012 Apr; 109 Suppl 3():22-6. PubMed ID: 22458488
[TBL] [Abstract][Full Text] [Related]
24. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
Wang W; Bergh A; Damber JE
Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.
Hall RE; Horsfall DJ; Stahl J; Vivekanandan S; Ricciardelli C; Stapleton AM; Scardino PT; Neufing P; Tilley WD
Prostate; 2004 Feb; 58(2):103-8. PubMed ID: 14716735
[TBL] [Abstract][Full Text] [Related]
26. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
Delatour NL; Mai KT
Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
[TBL] [Abstract][Full Text] [Related]
27. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract.
Häggman MJ; Adolfsson J; Khoury S; Montie JE; Norlén J
Scand J Urol Nephrol Suppl; 2000; (205):44-9. PubMed ID: 11144903
[TBL] [Abstract][Full Text] [Related]
28. Increased serum level of early prostate cancer antigen is associated with subsequent cancer risk in men with high-grade prostatic intraepithelial neoplasia.
Zhao Z; Zeng G
Endocr Relat Cancer; 2010 Jun; 17(2):505-12. PubMed ID: 20308359
[TBL] [Abstract][Full Text] [Related]
29. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
[TBL] [Abstract][Full Text] [Related]
30. [Intraepithelial prostatic neoplasia].
Stepanov VN; Frank GA; Dzhioev RR
Urol Nefrol (Mosk); 1999; (1):16-9. PubMed ID: 11149338
[TBL] [Abstract][Full Text] [Related]
31. High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon.
Angwafo FF; Zaher A; Befidi-Mengue R; Wonkam A; Takougang I; Powell I; Murphy G;
Prostate Cancer Prostatic Dis; 2003; 6(1):34-8. PubMed ID: 12664062
[TBL] [Abstract][Full Text] [Related]
32. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
35. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population.
Gokden N; Roehl KA; Catalona WJ; Humphrey PA
Urology; 2005 Mar; 65(3):538-42. PubMed ID: 15780372
[TBL] [Abstract][Full Text] [Related]
36. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
Scattoni V; Montironi R; Mazzucchelli R; Freschi M; Nava L; Losa A; Terrone C; Scarpa RM; Montorsi F; Pappagallo G; Rigatti P
BJU Int; 2006 Jul; 98(1):54-8. PubMed ID: 16831143
[TBL] [Abstract][Full Text] [Related]
37. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
38. Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance.
Montironi R; Mazzucchelli R; Lopez-Beltran A; Scarpelli M; Cheng L
BJU Int; 2011 Nov; 108(9):1394-401. PubMed ID: 21883826
[TBL] [Abstract][Full Text] [Related]
39. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
40. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research.
Marshall JR
IARC Sci Publ; 2001; 154():191-8. PubMed ID: 11220658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]